Drugs / FIA586
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04993157 | Dec 2021 → Jun 2022 | — | Novartis Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FIA586 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04993157 ↗ |
| Route | Oral | “single oral dose” NCT04993157 ↗ |